Anti-GD2 Antibody-Cytokine Fusion Protein, IgG (ch14.18)-TNFα (CAT#: ACFP-SH144)

This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-GD2 IgG to TNFα. It was expressed in CHO and purified with affinity chromatography. The immunocytokine retains the ability to bind the GD2 as well as the biological activity of TNFα. The fusion protein is comprised of an immunoglobulin heavy chain having a specificity for the target cell and a cytokine lymphotoxin, joined via its amino terminal amino acid to the carboxy-terminus of the immunoglobulin. This immunocytokine was designed for treating GD2-positive tumors.


Specific Inquiry
  • Size:
  • Conjugation:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Target
  • GD2
  • Molecule Class
  • L Kappa; IgG1-TNFα
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Clone
  • ch14.18
  • Related Disease
  • GD2-positive tumors
  • Cytokine 1
  • TNFα
  • Cytokines 1 Description
  • Tumor necrosis factor (TNF, tumor necrosis factor alpha, TNFα, cachexin, or cachectin) is a cell signaling protein (cytokine) involved in systemic inflammation and is one of the cytokines that make up the acute phase reaction. It is produced chiefly by activated macrophages, although it can be produced by many other cell types such as CD4+ lymphocytes, NK cells, neutrophils, mast cells, eosinophils, and neurons. The primary role of TNF is in the regulation of immune cells. TNF, being an endogenous pyrogen, is able to induce fever, apoptotic cell death, cachexia, inflammation and to inhibit tumorigenesis and viral replication and respond to sepsis via IL1 & IL6 producing cells. Dysregulation of TNF production has been implicated in a variety of human diseases including Alzheimer's disease, cancer, major depression, Psoriasis and inflammatory bowel disease (IBD). While still controversial, studies of depression and IBD are currently being linked to TNF levels. Recombinant TNF is used as an immunostimulant under the INN tasonermin. TNF can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated.
  • Cytokine 1 Species
  • Human
  • Applications
  • This product can be used therapeutically to deliver biologically active ligands to a desired tissue.

Target

  • Alternative Names
  • Disialoganglioside GD2; Ganglioside G2; GD2

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone ch14.18"

See other products for "GD2"

Single-domain Antibody

CAT Product Name Application Type
NAB-770-sdAb Recombinant Anti-Human GD2 VHH Single Domain Antibody Neut, ChiP, IP, FUNC Llama VHH

Chimeric Antibody

CAT Product Name Application Type
TAB-731 Anti-GD2 Recombinant Antibody (Dinutuximab) Neut, ELISA, IF, IP, FuncS, FC, ICC IgG1 - kappa

Immunotoxin

CAT Product Name Application Type
AGTO-L018R anti-GD2 immunotoxin 14G2a (IgG)-RTA Cytotoxicity assay, Functional assay

Recombinant Antibody

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-731 Afuco™ Anti-GD2 ADCC Recombinant Antibody (Dinutuximab), ADCC Enhanced Neut, ELISA, IF, IP, FuncS, FC ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for ACFP-SH144. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare